Recommendations for the transfusion of red blood cells.

The transfusion of red cell concentrates (RCC) is indicated in order to achieve a fast increase in the supply of oxygen to the tissues, when the concentration of haemoglobin (Hb) is low and/or the oxygen carrying capacity is reduced, in the presence of inadequate physiological mechanisms of compensation (table I)1–14. Table I Mechanisms of adaptation to anaemia Tissue oxygenation depends on various factors - the concentration of Hb; - the saturation of Hb, which, in turn, depends on the O2 tension and the affinity of the Hb for O2; - the O2 requirement, that is, the volume of oxygen needed by the tissues to carry out their aerobic function. Clinical factors that affect the physiological mechanisms of adaptation to anaemia5–8,15–19 - a reduced increase in cardiac output: hypovolaemia, coronary artery disease, disorders of heart valves, congestive heart disease, negative inotropic drugs; - decreased capacity to increase the extraction of O2: acute respiratory distress syndrome (ARDS), sepsis, systemic inflammatory response syndrome (SIRS), traumatic ischaemia-reperfusion damage syndrome; - altered gas exchange: chronic obstructive pulmonary disease (COPD), ARDS; - increased consumption of O2: fever, pain, stress, sepsis, SIRS, hyperventilation syndromes. When there is an indication to correct anaemia, but the situation is not urgent, strategies other than transfusion are preferred, such as the use of haematopoietic drugs (iron, vitamin B12, folic acid, recombinant erythropoietin)5–8,20. In order to reduce perioperative bleeding, it is important to suspend treatment with platelet anti-aggregants, adapt/neutralise anticoagulant therapy and use drugs such as antifibrinolytics and desmopressin9,20–23. Autotransfusion, carried out according to the criteria set out in the appropriate pre-operative request schemes (maximum surgical blood order schedule -MSBOS), and surgical and anaesthetic techniques to limit blood loss are useful strategies for decreasing the use of homologous blood (Grade of recommendation: 1C+)5,6,13,14,20–24.

[1]  G. Guyatt,et al.  Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[2]  J. Loscalzo,et al.  Anemia‐induced increase in the bleeding time:implications for treatment of nonsurgical blood loss , 2001, Transfusion.

[3]  P. Hebert,et al.  Review of published recommendations and guidelines for the transfusion of allogeneic red blood cells and plasma. , 1997 .

[4]  J. Wood,et al.  Guidelines for implementation of a maximum surgical blood order schedule. The British Committee for Standards in Haematology Blood Transfusion Task Force. , 2008, Clinical and laboratory haematology.

[5]  C. Pegelow,et al.  A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. , 1995, The New England journal of medicine.

[6]  P. Davies,et al.  A new formula for blood transfusion volume in the critically ill , 2005, Archives of Disease in Childhood.

[7]  R. Martineau,et al.  A Pilot Trial Evaluating the Clinical Effects of Prolonged Storage of Red Cells , 2005, Anesthesia and analgesia.

[8]  C. Rodeck,et al.  Transfusion guidelines for neonates and older children , 2004, British journal of haematology.

[9]  V. Lawrence,et al.  Perioperative blood transfusion and postoperative mortality. , 1998, JAMA.

[10]  Christopher G Ellis,et al.  The microcirculation as a functional system , 2005, Critical care.

[11]  N. Olivieri The beta-thalassemias. , 1999, The New England journal of medicine.

[12]  Joon-Oh Park,et al.  Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer , 2005, Cancer Chemotherapy and Pharmacology.

[13]  M. Osaki,et al.  Expression of erythropoietin receptor in human Merkel cell carcinoma of the eyelid. , 2006, Anticancer research.

[14]  A. Laupacis,et al.  Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. , 1998, The British journal of surgery.

[15]  C. Ince,et al.  Assessment of regional tissue oxygenation , 1999, Intensive Care Medicine.

[16]  H. Krumholz,et al.  Blood transfusion in elderly patients with acute myocardial infarction. , 2001, The New England journal of medicine.

[17]  P. Davies,et al.  Calculating the required transfusion volume in children , 2007, Transfusion.

[18]  Chris A Rogers,et al.  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.

[19]  R. Reiling Perioperative red cell transfusion. , 1990, Ohio medicine : journal of the Ohio State Medical Association.

[20]  Scott T. Miller,et al.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. , 1998, The New England journal of medicine.

[21]  P. Van der Linden,et al.  Physiologic aspects of anemia. , 2004, Critical care clinics.

[22]  M. Dicato Anemia in cancer: some pathophysiological aspects. , 2003, The oncologist.

[23]  P. Dendy,et al.  Guidelines on gamma irradiation of blood components for the prevention of transfusion‐associated graft‐versus‐host disease , 1996, Transfusion medicine.

[24]  R. C. Dennis,et al.  Limitations of the hematocrit level to assess the need for red blood cell transfusion in hypovolemic anemic patients , 2006, Transfusion.

[25]  N. Heddle,et al.  Biologic effects of leukocytes present in transfused cellular blood products. , 1994, Blood.

[26]  W. Pevec,et al.  A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. , 1997, American journal of surgery.

[27]  R. Califf,et al.  International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. , 2008, The American journal of cardiology.

[28]  C. Borchgrevink,et al.  The Role of Red Cells in Haemostasis: the Relation between Haematocrit, Bleeding Time and Platelet Adhesiveness , 1961, British journal of haematology.

[29]  J. Marshall,et al.  Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? , 2001, Critical care medicine.

[30]  S. Hill,et al.  Transfusion triggers: a systematic review of the literature. , 2002, Transfusion medicine reviews.

[31]  P. Rebulla,et al.  The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. , 2006, Haematologica.

[32]  J. Silber,et al.  A modified transfusion program for prevention of stroke in sickle cell disease. , 1992, Blood.

[33]  N. Roubinian,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2016, The Cochrane database of systematic reviews.

[34]  M. Telen Principles and problems of transfusion in sickle cell disease. , 2001, Seminars in hematology.

[35]  L. Sprague,et al.  Split Course Hyperfractionated Accelerated Radio-Chemotherapy (SCHARC) for patients with advanced head and neck cancer: Influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis , 2006, BMC Cancer.

[36]  T. Ratko,et al.  Evidence‐based recommendations for the use of WBC‐reduced cellular blood components , 2001, Transfusion.

[37]  J. Wallis,et al.  Nitric oxide and blood: a review , 2005, Transfusion medicine.

[38]  R. Califf,et al.  Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. , 2008, American heart journal.

[39]  J. Marshall,et al.  Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study , 1999, Critical care.

[40]  R. Adams,et al.  Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trial , 2001, Transfusion.

[41]  P. Tiberghien,et al.  Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice.Société Française de Greffe de Moelle. , 2000, Bone marrow transplantation.

[42]  R. Rodgers,et al.  Bleeding time: a guide to its diagnostic and clinical utility. , 1990, Archives of pathology & laboratory medicine.

[43]  K. Blackwell,et al.  Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? , 2004, The oncologist.

[44]  G. Remuzzi,et al.  URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS , 1982, The Lancet.

[45]  C. Manno,et al.  Guidelines for assessing appropriateness of pediatric transfusion , 2002, Transfusion.

[46]  M. Stevenson,et al.  Anemia, tumor hypoxemia, and the cancer patient. , 2005, International journal of radiation oncology, biology, physics.

[47]  V. Cocquyt,et al.  Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. , 2003, Critical reviews in oncology/hematology.

[48]  C. Wardrop,et al.  Consensus on red cell transfusion , 1995, BMJ.

[49]  S. Miller,et al.  Effect of transfusion in acute chest syndrome of sickle cell disease. , 1995, The Journal of pediatrics.

[50]  R. Storb,et al.  Transfusion problems associated with transplantation. , 1981, Seminars in hematology.

[51]  J. Duguid,et al.  Guidelines for the clinical use of red cell transfusions , 2001, British journal of haematology.

[52]  Scott T. Miller,et al.  Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. , 1995, The Journal of pediatrics.

[53]  J. Carson,et al.  Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion , 2002, Transfusion.

[54]  Kaaron Benson,et al.  Guide to the Preparation, Use and Quality Assurance of Blood Components , 1999 .

[55]  C. Ho The hemostatic effect of adequate red cell transfusion in patients with anemia and thrombocytopenia , 1996, Transfusion.

[56]  J. Hess,et al.  Buffering and dilution in red blood cell storage , 2006, Transfusion.

[57]  B. Larke,et al.  Guidelines for red blood cell and plasma transfusion for adults and children. , 1997, The International journal of risk & safety in medicine.

[58]  C. Forbes,et al.  Contribution of the haematocrit to the bleeding time. , 1983, Haemostasis.

[59]  R. Weiskopf,et al.  Anemia and perioperative red blood cell transfusion: a matter of tolerance. , 2006, Critical care medicine.

[60]  D. Dorr,et al.  Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. , 2008, JAMA.

[61]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[62]  J. Mcfarland Perioperative blood transfusions: indications and options. , 1999, Chest.

[63]  H. Chaplin Frozen red cells revisited. , 1984, The New England journal of medicine.

[64]  M. Aglietta,et al.  The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients , 2006, British Journal of Cancer.

[65]  S. Chien,et al.  Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels , 1987, Transfusion.

[66]  P. Hebert,et al.  REVIEW OF THE CLINICAL PRACTICE LITERATURE ON ALLOGENEIC RED BLOOD CELL TRANSFUSION , 1997 .

[67]  C. Valeri,et al.  The volume of blood shed during the bleeding time correlates with the peripheral venous hematocrit. , 1997, American journal of clinical pathology.

[68]  Michael J. Bernstein Perioperative red cell transfusion. , 1988, National Institutes of Health consensus development conference consensus statement.

[69]  A. Laupacis,et al.  A Meta-analysis of the Effectiveness of Cell Salvage to Minimize Perioperative Allogeneic Blood Transfusion in Cardiac and Orthopedic Surgery , 1999 .

[70]  P. Vaupel,et al.  Hypoxia and anemia: effects on tumor biology and treatment resistance. , 2005, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[71]  C. Pallister,et al.  The impact of anaemia on outcome in cancer. , 2005, Clinical and laboratory haematology.

[72]  B. Brozović Leucocyte depletion of blood and blood components , 1994 .

[73]  S. Knowles,et al.  Guidelines for compatibility procedures in blood transfusion laboratories , 2004, Transfusion medicine.

[74]  T. Prior,et al.  Transfusion-associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor. , 2000, American journal of clinical pathology.

[75]  N. Olivieri The β-Thalassemias , 1999 .

[76]  L. Dahners,et al.  Correlation of transfusion volume to change in hematocrit , 2006, American journal of hematology.

[77]  D. Prati Benefits and Complications of Regular Blood Transfusion in Patients with Beta-Thalassaemia major , 2000, Vox Sanguinis.

[78]  H. Reesink,et al.  Perioperative triggers for red cell transfusions , 2002, Vox sanguinis.

[79]  W. Vaughn,et al.  Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome , 1999, Transfusion.

[80]  G. Escolar,et al.  Experimental basis for the use of red cell transfusion in the management of anemic‐thrombocytopenic patients , 1988, Transfusion.

[81]  H. Clark,et al.  Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta‐analysis of unconfounded studies , 1998, The British journal of surgery.

[82]  Sunil V. Rao,et al.  Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. , 2004, JAMA.

[83]  M. Eugster,et al.  The influence of the haematocrit on primary haemostasis in vitro , 2005, Thrombosis and Haemostasis.

[84]  K. Ohene‐Frempong Indications for red cell transfusion in sickle cell disease. , 2001, Seminars in hematology.

[85]  Y. Huang Monitoring oxygen delivery in the critically ill. , 2005, Chest.

[86]  D. Fergusson,et al.  Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. , 2003, Transfusion medicine reviews.

[87]  M. Cazzola,et al.  A moderate transfusion regimen may reduce iron loading in beta‐ thalassemia major without producing excessive expansion of erythropoiesis , 1997, Transfusion.

[88]  L. Williamson,et al.  Preoperative blood transfusions for sickle cell disease. , 2001, The Cochrane database of systematic reviews.

[89]  N. Arya,et al.  The red cell storage lesion and its implication for transfusion. , 1997, Transfusion science.

[90]  P. Hebert,et al.  Review of physiologic mechanisms in response to anemia , 1997 .

[91]  J. Vincent,et al.  Anemia and blood transfusion in critically ill patients. , 2002, JAMA.

[92]  R. Strauss Transfusion Approach to Neonatal Anemia , 2000 .

[93]  G. Scambia,et al.  Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome. , 2006, Gynecologic oncology.

[94]  C. Jersild [Use of leukocyte-depleted blood components]. , 1997, Ugeskrift for laeger.

[95]  P. Hamilton,et al.  Guidelines on the management of massive blood loss , 2006, British journal of haematology.

[96]  D. Durand,et al.  Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions , 1985, British journal of haematology.

[97]  S. Lewis,et al.  British Committee for Standards in Haematology , 1969 .